748
Participants
Start Date
June 15, 2017
Primary Completion Date
October 15, 2021
Study Completion Date
October 15, 2021
Propofol
Propofol is infused continuously via the target-controlled infusion device (Orchestra®, Fresenius vial, Brezins, France), and the effect-site concentration is maintained within 0.5-2.0 μg/ml.
Dexmedetomidine
Dexmedetomidine is diluted with 0.9% saline to make a concentration of 4 μg/ml. As a loading dose, 1 μg/kg dexmedetomidine is administered over a 10-min period, which is then administered continuously at 0.1-0.5 μg/kg/h.
Seoul National University Bundang Hospital, Seongnam-si
Seoul National University Bundang Hospital
OTHER